Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. is positioned for robust future growth, underpinned by potential acquisitions expected to increase by $600 million in 2026, alongside strong performance from its Trilogy segment, which is benefiting from favorable industry trends and improved occupancy. With projections indicating a two-year compound annual growth rate (CAGR) of 11.8% for its seniors housing and skilled nursing facilities and 15.5% for its SHOP segment, the company is poised for significant organic growth driven by an enhanced skill mix and improved Medicare reimbursement rates. Furthermore, the recent improvement in AHR's cost of capital allows management to pursue capital deployment opportunities more aggressively, suggesting that external growth may exceed earlier expectations.

Bears say

American Healthcare REIT Inc. faces potential earnings challenges due to economic headwinds and regulatory changes that could adversely affect tenant performance and impede the company’s ability to meet earnings expectations. Significant risks, including tenant defaults and a downturn in the healthcare industry, could negatively impact the trust's revenues, especially given that a substantial portion of its net operating income derives from skilled nursing facilities. Additionally, pressures from rising construction costs, a competitive market for transactions, and volatility in capital markets could further strain profitability and hinder organic growth aspirations.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $52.83, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $52.83, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.